{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T14:07:12Z","timestamp":1779286032722,"version":"3.51.4"},"reference-count":26,"publisher":"Japanese Pharmacological Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharmacol Sci"],"published-print":{"date-parts":[[2009]]},"DOI":"10.1254\/jphs.09148fp","type":"journal-article","created":{"date-parts":[[2009,11,20]],"date-time":"2009-11-20T06:12:39Z","timestamp":1258697559000},"page":"260-268","source":"Crossref","is-referenced-by-count":27,"title":["NADPH Oxidase Isoforms and Anti-hypertensive Effects of Atorvastatin Demonstrated in Two Animal Models"],"prefix":"10.1254","volume":"111","author":[{"given":"Wenhao","family":"Cui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuniharu","family":"Matsuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumi","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Ibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Katsuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Kakehi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanako","family":"Ikami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihiro","family":"Yabe-Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Cakir Y, Ballinger SW. Reactive species-mediated regulation of cell signaling and the cell cycle: the role of MAPK. Antioxid Redox Signal. 2005;7:726–740.","DOI":"10.1089\/ars.2005.7.726"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Lambeth JD. Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy. Free Radic Biol Med. 2007;43:332–347.","DOI":"10.1016\/j.freeradbiomed.2007.03.027"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Kakehi T, Yabe-Nishimura C. NOX enzymes and diabetic complications. Semin Immunopathol. 2008;30:301–314.","DOI":"10.1007\/s00281-008-0122-7"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00044.2005"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.573709"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Gavazzi G, Deffert C, Trocme C, Schappi M, Herrmann FR, Krause KH. NOX1 deficiency protects from aortic dissection in response to angiotensin II. Hypertension. 2007;50:189–196.","DOI":"10.1161\/HYPERTENSIONAHA.107.089706"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.108.181925"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Habibi J, Whaley-Connell A, Qazi MA, Hayden MR, Cooper SA, Tramontano A, et al. Rosuvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, decreases cardiac oxidative stress and remodeling in Ren2 transgenic rats. Endocrinology. 2007;148:2181–2188.","DOI":"10.1210\/en.2006-1355"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Tajima N, Kurata H, Nakaya N, Mizuno K, Ohashi Y, Kushiro T, et al. Pravastatin reduces the risk for cardiovascular disease in Japanese hypercholesterolemic patients with impaired fasting glucose or diabetes: diabetes subanalysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study. Atherosclerosis. 2008;199:455–462.","DOI":"10.1016\/j.atherosclerosis.2008.05.027"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1161\/hc3001.092039"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1080\/10715760701885380"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1161\/hq0202.104081"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Whaley-Connell A, Habibi J, Nistala R, Cooper SA, Karuparthi PR, Hayden MR, et al. Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment. Hypertension. 2008;51:474–480.","DOI":"10.1161\/HYPERTENSIONAHA.107.102467"},{"issue":"1","key":"14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0031-6997(24)01434-0","volume":"52","author":"KIM S","year":"2000","ISSN":"https:\/\/id.crossref.org\/issn\/0031-6997","issn-type":"print"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.3317\/jraas.2006.003"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M809460200"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(92)90362-G"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Yang R, Powell-Braxton L, Ogaoawara AK, Dybdal N, Bunting S, Ohneda O, et al. Hypertension and endothelial dysfunction in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol. 1999;19:2762–2768.","DOI":"10.1161\/01.ATV.19.11.2762"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1253\/circj.68.1067"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Dikalov SI, Dikalova AE, Bikineyeva AT, Schmidt HH, Harrison DG, Griendling KK. Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production. Free Radic Biol Med. 2008;45:1340–1351.","DOI":"10.1016\/j.freeradbiomed.2008.08.013"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1161\/hq1101.098486"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Martyn KD, Frederick LM, von Loehneysen K, Dinauer MC, Knaus UG. Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell Signal. 2006;18:69–82.","DOI":"10.1016\/j.cellsig.2005.03.023"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.35.25051"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1038\/85259"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000143319.73503.38"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1161\/hh0901.089987"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T10:02:14Z","timestamp":1739440934000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jphs\/111\/3\/111_09148FP\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1254\/jphs.09148fp","relation":{},"ISSN":["1347-8613","1347-8648"],"issn-type":[{"value":"1347-8613","type":"print"},{"value":"1347-8648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009]]}}}